Astex Therapeutics Limited
22 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 6 name spellings.
6
Ending by 2030
Oct 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Pharmaceutical Compositions Comprising N-(3,5-Dimethoxyphenyl)-N'-(1-Methylethyl)-N-[3-(1-Methyl-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-Diamine (US 11,684,620) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Mar 24, 2027The maintenance fee for Quinoxaline Derivatives Useful as FGFR Kinase Modulators (US 10,421,747) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
- 1 fee due Apr 13, 2027The maintenance fee for Bicyclic heterocycle compounds and their uses in therapy (US 9,155,743) comes due Apr 13, 2027. Unpaid by Oct 13, 2027, it lapses early.
- 1 fee due May 26, 2027The maintenance fee for Nrf2 REGULATORS (US 10,485,806) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Pyrazolyl Quinoxaline Kinase Inhibitors (US 10,519,137) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for Bicyclic Heterocycle Compounds and Their Uses in Therapy (US 11,866,428) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 3 fees due Sep 5 to 26, 2027 · next Sep 5
- 5 fees due Oct 5 to 14, 2027 · next Oct 5
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
- 2 terms have ended since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,071,614 | Bicyclic Heterocyclic Compounds as Protein Tyrosine Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 8,076,354 | Bicyclic Heterocyclic Compounds as Protein Tyrosine Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 8,796,293 | Purine and deazapurine derivatives as pharmaceutical compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 9,416,136 | Pyrrolopyrimidine Compounds and Their Uses In force · High confidence | In force | High confidence | |
| US 8,895,745 | Bicyclic heterocyclic compounds as FGFR inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 8,131,527 | FGFR pharmacophore compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 9,464,071 | Pyrazolyl Quinoxaline Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 10,519,137 | Pyrazolyl Quinoxaline Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 9,850,228 | Pyrazolyl Quinoxaline Kinase Inhibitors In force · High confidence | In force | High confidence | |
| US 9,290,478 | Substituted Quinoxalines as FGFR Kinase Inhibitors In force · High confidence | In force | High confidence |
Also on record, not counted in the 64: 22 patents in force now held by others · 53 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 pending · 34 abandoned · 33 no status recorded